ACSL3 Knockout HAP1 Cell Line

ACSL3 Knockout HAP1 Cell Line
Cat.No.:

EDC08005

Species:

Human

Cell Name:

HAP1

Gene:

ACSL3

Gene ID:

2181

Size:

1×10⁶cells

ACSL3 Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC08005
Product Name ACSL3 Knockout HAP1 Cell Line
Species Human
Cell Line HAP1
Cellosaurus ID CVCL_0F62
Gene ID
Cell Line Synonyms Highly Aggressively Proliferating Immortalized
Gene ACSL3
Summary
The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme is highly expressed in brain, and preferentially utilizes myristate, arachidonate, and eicosapentaenoate as substrates. The amino acid sequence of this isozyme is 92% identical to that of rat homolog. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Digestion Time 2 min
Morphology Adherent
Passage Ratio 1:8~1:10
Complete Culture Medium IMDM+10%FBS
Freezing Medium 90%FBS+10%DMSO
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Required Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: